Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9Y2I7 (FYV1_HUMAN)

Last modified November 3, 2009. Version 86. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    1-phosphatidylinositol-3-phosphate 5-kinase
      Short name=Phosphatidylinositol-3-phosphate 5-kinase
    EC=2.7.1.150
Alternative name(s):
    FYVE finger-containing phosphoinositide kinase
    PIKfyve
    Phosphatidylinositol-3-phosphate 5-kinase type III
    Type III PIP kinase
      Short name=PIPkin-III
Gene names
Name: PIKFYVE
Synonyms: KIAA0981, PIP5K3
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length2098 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2). Catalyzes the phosphorylation of phosphatidylinositol-3-phosphate on the fifth hydroxyl of the myo-inositol ring, to form phosphatidylinositol-3,5-bisphosphate. Required for endocytic-vacuolar pathway and nuclear migration. Plays a role in the biogenesis of endosome carrier vesicles (ECV)/ multivesicular bodies (MVB) transport intermediates from early endosomes. Ref.8

Catalytic activity

ATP + 1-phosphatidyl-1D-myo-inositol 3-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate.

Subunit structure

Component of the PI(3,5)P2 regulatory complex/PAS complex, at least composed of PIKFYVE, FIG4 and VAC14. VAC14 nucleates the assembly of the complex and serves as a scaffold.

Subcellular location

Endosome membrane. Note: Mainly associated with membranes of the late endocytic pathway. Ref.8 Ref.4

Involvement in disease

Defects in PIKFYVE are the cause of corneal fleck dystrophy (CFD) [MIM:121850]. CFD is an autosomal dominant disorder of the cornea characterized by numerous small white flecks scattered in all levels of the stroma. Although CFD may occasionally cause mild photophobia, patients are typically asymptomatic and have normal vision. Ref.12

Sequence similarities

Contains 1 DEP domain.

Contains 1 FYVE-type zinc finger.

Contains 1 PIPK domain.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 209820981-phosphatidylinositol-3-phosphate 5-kinase
PRO_0000185452

Regions

Domain365 – 44076DEP
Domain1758 – 2084327PIPK
Zinc finger158 – 21861FYVE-type
Region1842 – 2098257Catalytic

Amino acid modifications

Modified residue71Phosphothreonine Ref.10
Modified residue461Phosphotyrosine Ref.5
Modified residue761Phosphoserine Ref.10
Modified residue2991Phosphoserine Ref.10
Modified residue3071Phosphoserine Ref.10
Modified residue3181Phosphoserine Ref.11
Modified residue3291Phosphoserine Ref.11
Modified residue3521Phosphoserine Ref.10
Modified residue11551Phosphotyrosine Ref.7
Modified residue15441Phosphoserine Ref.10
Modified residue15491Phosphoserine Ref.10
Modified residue17541Phosphoserine Ref.10
Modified residue17721Phosphotyrosine Ref.6

Natural variations

Natural variant6171M → V: dbSNP rs16840913.
VAR_057097
Natural variant10331S → A: dbSNP rs999890.
VAR_057098
Natural variant11031K → R in CFD. Ref.12
VAR_025309
Natural variant18581R → Q: dbSNP rs2289170.
VAR_057099

Sequences

Sequence LengthMass (Da)Tools
Q9Y2I7-1 [UniParc].

Last modified May 10, 2004. Version 2.
Checksum: 174B4102057292B7

FASTA2,098237,108
        10         20         30         40         50         60 
MATDDKTSPT LDSANDLPRS PTSPSHLTHF KPLTPDQDEP PFKSAYSSFV NLFRFNKERA 

        70         80         90        100        110        120 
EGGQGEQQPL SGSWTSPQLP SRTQSVRSPT PYKKQLNEEL QRRSSALDTR RKAEPTFGGH 

       130        140        150        160        170        180 
DPRTAVQLRS LSTVLKRLKE IMEGKSQDSD LKQYWMPDSQ CKECYDCSEK FTTFRRRHHC 

       190        200        210        220        230        240 
RLCGQIFCSR CCNQEIPGKF MGYTGDLRAC TYCRKIALSY AHSTDSNSIG EDLNALSDSA 

       250        260        270        280        290        300 
CSVSVLDPSE PRTPVGSRKA SRNIFLEDDL AWQSLIHPDS SNTPLSTRLV SVQEDAGKSP 

       310        320        330        340        350        360 
ARNRSASITN LSLDRSGSPM VPSYETSVSP QANRTYVRTE TTEDERKILL DSVQLKDLWK 

       370        380        390        400        410        420 
KICHHSSGME FQDHRYWLRT HPNCIVGKEL VNWLIRNGHI ATRAQAIAIG QAMVDGRWLD 

       430        440        450        460        470        480 
CVSHHDQLFR DEYALYRPLQ STEFSETPSP DSDSVNSVEG HSEPSWFKDI KFDDSDTEQI 

       490        500        510        520        530        540 
AEEGDDNLAN SASPSKRTSV SSFQSTVDSD SAASISLNVE LDNVNFHIKK PSKYPHVPPH 

       550        560        570        580        590        600 
PADQKEYLIS DTGGQQLSIS DAFIKESLFN RRVEEKSKEL PFTPLGWHHN NLELLREENG 

       610        620        630        640        650        660 
EKQAMERLLS ANHNHMMALL QQLLHSDSLS SSWRDIIVSL VCQVVQTVRP DVKNQDDDMD 

       670        680        690        700        710        720 
IRQFVHIKKI PGGKKFDSVV VNGFVCTKNI AHKKMNSCIK NPKILLLKCS IEYLYREETK 

       730        740        750        760        770        780 
FTCIDPIVLQ EREFLKNYVQ RIVDVRPTLV LVEKTVSRIA QDMLLEHGIT LVINVKSQVL 

       790        800        810        820        830        840 
ERISRMTQGD LVMSMDQLLT KPHLGTCHKF YMQIFQLPNE QTKTLMFFEG CPQHLGCTIK 

       850        860        870        880        890        900 
LRGGSDYELA RVKEILIFMI CVAYHSQLEI SFLMDEFAMP PTLMQNPSFH SLIEGRGHEG 

       910        920        930        940        950        960 
AVQEQYGGGS IPWDPDIPPE SLPCDDSSLL ESRIVFEKGE QENKNLPQAV ASVKHQEHST 

       970        980        990       1000       1010       1020 
TACPAGLPCA FFAPVPESLL PLPVDDQQDA LGSELPESLQ QTVVLQDPKS QIRAFRDPLQ 

      1030       1040       1050       1060       1070       1080 
DDTGLYVTEE VTSSEDKRKT YSLAFKQELK DVILCISPVI TFREPFLLTE KGMRCSTRDY 

      1090       1100       1110       1120       1130       1140 
FAEQVYWSPL LNKEFKEMEN RRKKQLLRDL SGLQGMNGSI QAKSIQVLPS HELVSTRIAE 

      1150       1160       1170       1180       1190       1200 
HLGDSQSLGR MLADYRARGG RIQPKNSDPF AHSKDASSTS SGKSGSKNEG DEERGLILSD 

      1210       1220       1230       1240       1250       1260 
AVWSTKVDCL NPINHQRLCV LFSSSSAQSS NAPSACVSPW IVTMEFYGKN DLTLGIFLER 

      1270       1280       1290       1300       1310       1320 
YCFRPSYQCP SMFCDTPMVH HIRRFVHGQG CVQIILKELD SPVPGYQHTI LTYSWCRICK 

      1330       1340       1350       1360       1370       1380 
QVTPVVALSN ESWSMSFAKY LELRFYGHQY TRRANAEPCG HSIHHDYHQY FSYNQMVASF 

      1390       1400       1410       1420       1430       1440 
SYSPIRLLEV CVPLPKIFIK RQAPLKVSLL QDLKDFFQKV SQVYVAIDER LASLKTDTFS 

      1450       1460       1470       1480       1490       1500 
KTREEKMEDI FAQKEMEEGE FKNWIEKMQA RLMSSSVDTP QQLQSVFESL IAKKQSLCEV 

      1510       1520       1530       1540       1550       1560 
LQAWNNRLQD LFQQEKGRKR PSVPPSPGRL RQGEESKISA MDASPRNISP GLQNGEKEDR 

      1570       1580       1590       1600       1610       1620 
FLTTLSSQSS TSSTHLQLPT PPEVMSEQSV GGPPELDTAS SSEDVFDGHL LGSTDSQVKE 

      1630       1640       1650       1660       1670       1680 
KSTMKAIFAN LLPGNSYNPI PFPFDPDKHY LMYEHERVPI AVCEKEPSSI IAFALSCKEY 

      1690       1700       1710       1720       1730       1740 
RNALEELSKA TQWNSAEEGL PTNSTSDSRP KSSSPIRLPE MSGGQTNRTT ETEPQPTKKA 

      1750       1760       1770       1780       1790       1800 
SGMLSFFRGT AGKSPDLSSQ KRETLRGADS AYYQVGQTGK EGTENQGVEP QDEVDGGDTQ 

      1810       1820       1830       1840       1850       1860 
KKQLINPHVE LQFSDANAKF YCRLYYAGEF HKMREVILDS SEEDFIRSLS HSSPWQARGG 

      1870       1880       1890       1900       1910       1920 
KSGAAFYATE DDRFILKQMP RLEVQSFLDF APHYFNYITN AVQQKRPTAL AKILGVYRIG 

      1930       1940       1950       1960       1970       1980 
YKNSQNNTEK KLDLLVMENL FYGRKMAQVF DLKGSLRNRN VKTDTGKESC DVVLLDENLL 

      1990       2000       2010       2020       2030       2040 
KMVRDNPLYI RSHSKAVLRT SIHSDSHFLS SHLIIDYSLL VGRDDTSNEL VVGIIDYIRT 

      2050       2060       2070       2080       2090 
FTWDKKLEMV VKSTGILGGQ GKMPTVVSPE LYRTRFCEAM DKYFLMVPDH WTGLGLNC 

« Hide

References

« Hide 'large scale' references
[1]"Human PIKfyve, a PI3P 5-kinase that regulates endocytic trafficking."
Cabezas A., Pattni K., Stenmark H.
Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Brain.
[2]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1073-2098.
Tissue: Brain.
[3]"Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."
Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.
DNA Res. 6:63-70(1999) [PubMed: 10231032] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1521-2098.
Tissue: Brain.
[4]"Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve endomembrane localization."
Sbrissa D., Ikonomov O.C., Shisheva A.
J. Biol. Chem. 277:6073-6079(2002) [PubMed: 11706043] [Abstract]
Cited for: SUBCELLULAR LOCATION.
[5]"Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry."
Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C.
Anal. Chem. 76:2763-2772(2004) [PubMed: 15144186] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-46, MASS SPECTROMETRY.
Tissue: T-cell.
[6]"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J.
Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1772, MASS SPECTROMETRY.
[7]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1155, MASS SPECTROMETRY.
Tissue: Epithelium.
[8]"Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex."
Sbrissa D., Ikonomov O.C., Fu Z., Ijuin T., Gruenberg J., Takenawa T., Shisheva A.
J. Biol. Chem. 282:23878-23891(2007) [PubMed: 17556371] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN THE PI(3,5)P2 REGULATORY COMPLEX.
[9]"ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality."
Sbrissa D., Ikonomov O.C., Fenner H., Shisheva A.
J. Mol. Biol. 384:766-779(2008) [PubMed: 18950639] [Abstract]
Cited for: IDENTIFICATION IN THE PI(3,5)P2 REGULATORY COMPLEX.
[10]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7; SER-76; SER-299; SER-307; SER-352; SER-1544; SER-1549 AND SER-1754, MASS SPECTROMETRY.
[11]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-318 AND SER-329, MASS SPECTROMETRY.
[12]"Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy."
Li S., Tiab L., Jiao X., Munier F.L., Zografos L., Frueh B.E., Sergeev Y., Smith J., Rubin B., Meallet M.A., Forster R.K., Hejtmancik J.F., Schorderet D.F.
Am. J. Hum. Genet. 77:54-63(2005) [PubMed: 15902656] [Abstract]
Cited for: VARIANT CFD ARG-1103.
+Additional computationally mapped references.

Cross-references

Sequence databases

AY457063 mRNA. Translation: AAR19397.1.
AK091482 mRNA. Translation: BAC03674.1.
AB023198 mRNA. Translation: BAA76825.1.
IPIIPI00396145.
RefSeqNP_055855.2.
UniGeneHs.173939

3D structure databases

ModBaseSearch...

Protein-protein interaction databases

STRINGQ9Y2I7.

PTM databases

PhosphoSiteQ9Y2I7.

Proteomic databases

PRIDEQ9Y2I7.

Genome annotation databases

EnsemblENST00000264380; ENSP00000264380; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000308862; ENSP00000308715; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000392200; ENSP00000376036; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000392202; ENSP00000376038; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000407449; ENSP00000384356; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000422495; ENSP00000414477; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000443896; ENSP00000407692; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000451223; ENSP00000410691; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000452564; ENSP00000405736; ENSG00000115020; Homo sapiens. [Genome view]
ENST00000453820; ENSP00000404713; ENSG00000115020; Homo sapiens. [Genome view]
GeneID200576.
KEGGhsa:200576.
UCSCuc002vcz.1. human.

Organism-specific databases

CTD200576.
GeneCardsGC02P208839.
H-InvDBHIX0002785.
HGNCHGNC:23785. PIKFYVE.
MIM121850. phenotype.
609414. gene.
Orphanet34533. Corneal dystrophy.
98970. Corneal flecked dystrophy, Francois-Neetens type.
PharmGKBPA128394599.
HUGESearch...
GenAtlasSearch...

Phylogenomic databases

HOGENOMQ9Y2I7.
HOVERGENQ9Y2I7.

Enzyme and pathway databases

BRENDA2.7.1.150. 247.
2.7.1.68. 247.

Gene expression databases

ArrayExpressQ9Y2I7.
BgeeQ9Y2I7.
CleanExHS_PIP5K3.
GenevestigatorQ9Y2I7.
GermOnlineENSG00000115020. Homo sapiens.

Family and domain databases

InterProIPR002423. Cpn60/TCP-1.
IPR002498. PInositol-4-P-5-kinase_core.
IPR016034. PInositol-4P-5-kinase_core_sub.
IPR000591. Pleckstrin/G-protein_interact.
IPR011991. Wing_hlx_DNA_bd.
IPR000306. Znf_FYVE.
IPR017455. Znf_FYVE-rel.
[Graphical view]
Gene3DG3DSA:1.10.10.10. Wing_hlx_DNA_bd. 1 hit.
PANTHERPTHR11353. Cpn60/TCP-1. 1 hit.
PfamPF00118. Cpn60_TCP1. 1 hit.
PF00610. DEP. 1 hit.
PF01363. FYVE. 1 hit.
PF01504. PIP5K. 1 hit.
[Graphical view]
SMARTSM00049. DEP. 1 hit.
SM00064. FYVE. 1 hit.
SM00330. PIPKc. 1 hit.
[Graphical view]
PROSITEPS50186. DEP. 1 hit.
PS51455. PIPK. 1 hit.
PS50178. ZF_FYVE. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio89946.
SOURCESearch...

Entry information

Entry nameFYV1_HUMAN
AccessionPrimary (citable) accession number: Q9Y2I7
Secondary accession number(s): Q8NB67
Entry history
Integrated into UniProtKB/Swiss-Prot: December 1, 2000
Last sequence update: May 10, 2004
Last modified: November 3, 2009
This is version 86 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 2

Human chromosome 2: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents